이상반응 보고

VAERS ID	1627541
성별	여성
나이	16세
주 코드	SC
제약회사	MODERNA
로트 번호
예방접종 횟수	1
접종일	2021-03-16
발병일	2021-03-16
상태	회복

증상

• 부적절한 연령의 환자에게 투여된 제품(Product administered to patient of inappropriate age)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

Patient was 16 yo at first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 16 yo at first dose) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
No Medical History information was reported.
On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.
On 16-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 16 yo at first dose).
On 16-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 16 yo at first dose) had resolved.
The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Concomitant product use was not reported.
No treatment information was reported.
Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received and contains non-significant information